KAPA
Kairos PharmaยทAMEX
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
KAPA Profile
Kairos Pharma, Ltd.
A small California-based biotechnology company focused on cancer
2355 Westwood Blvd., #139, Los Angeles CA 90064
--
Kairos Pharma, Ltd., was incorporated under the laws of the State of California on June 17, 2013 as NanoGB 13, Inc., and subsequently converted to a Delaware corporation on May 10, 2023 as Kairos Pharma, Ltd. The company is a clinical-stage biopharmaceutical company dedicated to the treatment of cancer patients, aiming to overcome key barriers in immunosuppression and drug resistance. These therapies include antibodies and small molecules for the treatment of prostate cancer, lung cancer, breast cancer and glioblastoma.
